Editor in Chief: Johannes Czernin, MD
University of California–Los Angeles
Founded in 1960, The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. JNM includes hot topics and state-of-the-art reports as well as clinical and basic science research in oncology, theranostics, neurology, cardiology, and radiation biology.
According to the 2023 Journal Citation Reports™ (released in June 2024), JNM ranks sixth in impact among 204 medical imaging journals worldwide.
- Impact factor – 9.1
- Five-year impact factor – 9.1
- Immediacy index – 2.6
- Total citations – 29,679
- Eigenfactor Score – 0.02795
- Article Influence Score – 2.606
JNM offers:
- Continuing education articles approved for 2.0 AMA/PRA category 1 credit and SAM credit
- VOICE-approved articles for continuing education credit
- More than 60 years of archived content—free with subscription
- Online access and search tools—free with subscription